Claim 1: the procedure of inducing immune response in human body, including the management of the first immune component of human body, the first component including one or more antigens and the first adjuvant, the second component including one or more antigens and more than one antigen. The second subject, the first and second components, had at least one common antigen,The first and second assistants include a TLR and / or an immunoactive sabanina, and at least one of them has a common component, the second assistant includes a common component, less than the first assistant, and / or the common antigen is RTS, S and the second component contain less RTs than the first component, provided that the first and second components do not include RTS, s and qs21, and 3D-MPL, related to oil emulsion formulations in water. Claim 9: procedure for any of the above claims,The first and second assistants included three d-mpls and one q21 for plasma preparation. Claim 17: any of the above claimed procedures in which the common antigen is a plasma antigen, such as P. falciparum or P. vivax. Claim 18: procedure for any of the above claims, i.e. the common antigen is an environmental protein or immune fragment or variant. Environmental requirements 26: immune components used in the process of inducing human immune response,The program includes the management of the first immune ingredient, including one or more antigens and the first adjuvant, and then the management of the second immune ingredient, including one or more antigens and the second adjuvant, The first and second components have at least one common antigen, the first and second components include a TLR and / or an immunoactive scabies, at least one common component, and the second component contains less common components than the first component. Collaborator,And / or co antigens are RTS, s, while the second component contains less RTs than the first component, provided that the first and second components do not con
